General Information of the Compound
Compound ID
CP0128522
Compound Name
2-amidino-4-iodobenzothiophene
    Show/Hide
Synonyms
B-428
    Show/Hide
Structure
Formula
C9H7IN2S
Molecular Weight
302.14
Canonical SMILES
NC(=N)c1cc2c(I)cccc2s1
    Show/Hide
InChI
InChI=1S/C9H7IN2S/c10-6-2-1-3-7-5(6)4-8(13-7)9(11)12/h1-4H,(H3,11,12)
    Show/Hide
InChIKey
YERQOXAYAFWFEJ-UHFFFAOYSA-N
Physicochemical Property
logP
2.78997
Rotatable Bonds
1
Heavy Atom Count
13
Polar Areas
49.87
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
2
Complexity
13

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 1747
ChEMBL ID
CHEMBL60088
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01043, Urokinase-type plasminogen activator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 320 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 210 nM
2 Ki = 79.43 nM
3 Ki = 210 nM
4 Ki = 320 nM
Clinical Information about the Compound
Drug 1 ( B-428 )
Drug Name B-428
Company Eisai Co Ltd
Indication
Solid tumour/cancer
Terminated
Target(s)
Urokinase-type plasminogen activator (PLAU)
Inhibitor